Navigation Links
ICAP Ocean Tomo Offers IP Portfolio of Near-Infrared Spectroscopy Technology
Date:7/6/2010

CHICAGO, July 6 /PRNewswire/ -- ICAP Ocean Tomo, the intellectual property brokerage division of ICAP plc (IAP.L), has been engaged to sell a patent portfolio of near-infrared spectroscopy technology owned by NIResults Inc. The portfolio includes over 90 issued US and foreign patents and patent applications.  The assets have been cited by over 20 companies including Abbott Laboratories, Baxter International, Bayer Healthcare, Beckman Coulter Inc., Xerox, and Hewlett Packard.

(Logo: http://photos.prnewswire.com/prnh/20100614/CG20517LOGO)

(Logo: http://www.newscom.com/cgi-bin/prnh/20100614/CG20517LOGO)

The patents of this portfolio cover the use of near-infrared spectroscopy in clinical chemistry analysis systems, pulse oximeters and CO-oximeters, non-invasive glucose monitors, and hemoglobin monitors. The patents describe a method for the monitoring of key blood analytes without the need for costly, environmentally challenging, chemical reagents. The assets also include in-vitro, which is applied to a droplet of blood from a sample, and in-vivo (non-invasive) technology, which does not require a blood sample. Using near-infrared spectroscopy technology to count analytes in the blood eliminates the disadvantages associated with conventional methods such as the risk of patient infection and discomfort from invasive sampling methods and erroneous test results due to time delays between when the blood is drawn and analyzed.

"This portfolio will provide the purchaser with the coverage necessary to develop next generation monitoring devices," said Dean Becker, ICAP Ocean Tomo CEO. This portfolio should be of interest to any entity involved in diabetes management or blood monitoring markets, or developing products for analyte measurement.

To learn more about the patents available for sale in this portfolio or how to sell or buy intellectual property please contact ICAP Ocean Tomo at 1-866-779-8363 or at patent.brokerage@us.icap.com.

About ICAP Ocean Tomo LLC

ICAP Ocean Tomo is the intellectual property brokerage division of ICAP.

About ICAP

ICAP is the world's premier interdealer broker and provider of post trade services. The Group matches buyers and sellers in the wholesale markets in interest rates, credit, commodities, foreign exchange, emerging markets, equities and equity derivatives through voice and electronic networks. ICAP is also the source of global market information and research for professionals in the international financial markets. ICAP plc was added to the FTSE 100 Index on 30 June 2006. For more information go to www.icap.com.


'/>"/>
SOURCE ICAP Ocean Tomo
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Q-Med AB and Oceana Therapeutics, Inc. Take Major Step Towards SOLESTA(TM) US Regulatory Filing
2. Oceanside Pharmaceuticals Announces Launch of Librax(R) AG
3. The Ocean Becomes a Pipeline To A Cure for Cystic Fibrosis
4. HealthWarehouse.com Now Offers Over 1,000 Medications Under $25 Bringing Increased Affordability to Consumers
5. BSGI Offers Improved Cancer Detection for Negative or Indeterminate Mammograms
6. In the Face of Pain® Offers Social Media 101 for Pain Management Advocates
7. Medicalequipmentpro.com Offers Fathers Day Discounts to Ensure this Fathers Day is a Healthy One
8. Prolifiq Offers Best Practices Solution for Selling Medical Devices in Tough Regulatory Environment
9. Gold Standard/Elsevier Offers Timely, Transparent, Reliable Drug Pricing Data, Including Average Wholesale Price (AWP)
10. Blog Contest Offers Graduate Students the Chance to Win a Trip to Zambia
11. BSGI Offers Clear View of Breast Tumor Response to Neoadjuvant Chemotherapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... 18, 2017  Tarix Orphan LLC today announced that ... Rare Pediatric Disease (RPD) designation for the company,s drug ... Bullosa (RDEB), a rare genetic skin disorder. There are ... limited to supportive care. "The RPD designation ... previously granted by the FDA in this indication," said ...
(Date:1/18/2017)... 18, 2017 ML Capital ... to publish an online presentation tomorrow, January 19 ... forecast for 2017. Management reports that the forecast ... sales performance from its existing operations, and the ... into the Cannabis sector through a partnership ...
(Date:1/18/2017)... WASHINGTON , Jan. 18, 2017  Robust ... higher rebates and discounts on medicine prices, according to ... Group (BRG). The study is among the first to ... biopharmaceutical companies, generic manufacturers, pharmacy benefit managers (PBMs), health ... "The BRG study is the first to show ...
Breaking Medicine Technology:
(Date:1/18/2017)... ... 2017 , ... Dr. Farhan Qureshi is an esteemed dentist who offers a ... practice has two convenient office locations in Alexandria and Arlington, Virginia. Recently, Find Local ... Alexandria area. This award confirms the fact that Dr. Qureshi’s patients have left ...
(Date:1/18/2017)... Switzerland (PRWEB) , ... January 18, 2017 , ... ... for the first time support an aid project with the donation of cochlear ... get the gift of hearing and thus a fair chance of leading an ...
(Date:1/18/2017)... ... January 18, 2017 , ... Floundering on New Year’s resolutions? ... the perfect time for a reset. The U.S. Apple Association agrees and recommends ... of the factors that contribute to heart disease. , The U.S. Apple Association – ...
(Date:1/17/2017)... York, NY (PRWEB) , ... January 17, 2017 , ... ... grand opening of a new showroom at South Dixie Hwy in Miami, FL. , ... Officer at Gym Source. “The new innovative in-store concept is designed to give clients ...
(Date:1/17/2017)... ... January 17, 2017 , ... Today, to help ... Francis re-releases powerfully uplifting interview with medical expert and prolific author, Dr. Bernie ... pass through tough times, Dr. Bernie Siegel energizes listeners to live life with ...
Breaking Medicine News(10 mins):